Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Incyte Corporation (INCY)

-NasdaqGS
107.69 Down 0.72(0.66%) May 22, 3:59PM EDT
|After Hours : 107.69 Up 0.02 (0.02%) May 22, 4:25PM EDT
Add to Portfolio
Prev Close:108.41
Open:108.00
Bid:N/A
Ask:142.50 x 100
1y Target Est:117.55
Beta:0.17
Earnings Date:Jul 29 - Aug 3 (Est.)
Day's Range:107.19 - 109.11
52wk Range:43.86 - 111.93
Volume:694,683
Avg Vol (3m):1,191,990
Market Cap:19.28B
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 0.66%19.28B
AMGNDown 0.16%124.37B
CELGDown 0.09%92.08B
RHHBYDown 0.94%N/A

Key Statistics

Forward P/E (1 yr):112.18
P/S (ttm):33.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-4.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback